Anterogen Co., Ltd.: Diabetic Foot trials
The registry lists 10 Diabetic Foot studies with Anterogen Co., Ltd. as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 3Phase 3 2No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical TrialRecruitingNCT06141811
- Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot UlcersRecruitingNCT04497805Phase 2
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical TrialCompletedNCT04590703
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.CompletedNCT04569409Phase 3
- Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot UlcersCompletedNCT03754465Phase 2
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.CompletedNCT03370874Phase 3
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical TrialCompletedNCT03183804
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical TrialCompletedNCT03183726
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot UlcersCompletedNCT02619877Phase 2
- Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot UlcersCompletedNCT02394886Phase 1